Agenus to Participate in Leerink Partners Global Biopharma Conference

LEXINGTON, Mass.--(BUSINESS WIRE)-- Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in discovering and developing novel immunological agents to treat various cancers, today announced that Dr. Garo Armen, Chairman and CEO, will participate in a fireside chat and investor one-on-ones at the upcoming Leerink Global Biopharma Conference on March 11th - 13th in Miami Beach, Florida. The fireside chat will take place at 2:30 p.m. ET on March 11th.

A live webcast and replay of the fireside chat will be accessible on the company’s website at https://investor.agenusbio.com/events-and-presentations.

About Agenus

Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus is headquartered in Lexington, MA. For more information, visit www.agenusbio.com or @agenus_bio. Information that may be important to investors will be routinely posted on our website and social media channels.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240226680978/en/

Investors
917-362-1370
[email protected]

Media
781-674-4784
[email protected]

Source: Agenus Inc.

You May Also Be Interested In

• Bouygues Telecom Becomes First Mobile Network Operator in France to Launch App-Free Nuisance Call Protection
• Finalsite Expands K-12 Payments Capabilities with RevTrak Acquisition
• Thunder Gold Intersects 232.5 Metres Averaging 0.450 g/t Au (Including 33.0 Metres Averaging 1.383 g/t Au) at Tower Mountain